Surgery alone improves survival in stage 2a/2b neuroblastoma

04/26/2012 | PhysiciansBriefing.com

Patients with low-risk asymptomatic stage 2a or 2b neuroblastoma who were treated with surgery alone had high five-year event-free and overall survival rates, Canadian researchers wrote in the Journal of Clinical Oncology. They assessed outcomes of 915 patients younger than 22 years and found that only 11.1% of them experienced disease recurrence or progression following surgery.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ